Comparison of wound healing effects between Oncorhynchus keta -derived polydeoxyribonucleotide (PDRN) and Oncorhynchus mykiss -derived PDRN

Polydeoxyribonucleotide (PDRN) influencing cellular growth and differentiation is recognized to promote wound healing by stimulating tissue repair. Although PDRN can be extracted from human placentas, PDRN medications have recently been extracted from the semen of trout ( ) and salmon ( ). The present study was designed to evaluate the wound healing effects of -derived PDRN for injection (Rejuvenex) and PDRN cream (Rejuvenex Cream) in comparison with those of -derived PDRN injection (Placentex). Full-thickness skin defects were made on the back of mice (n=60). The mice were divided into the following four groups according to the dressing used for the wounds: -derived PDRN injection group, -derived PDRN injection group, -derived PDRN cream group, and normal saline soaked dressing group (control group). We analyzed the gross findings, wound sizes, histological findings, immunohistochemistry and enzyme-linked immunosorbent assays for the groups immediately after the treatment, and again after 4, 7, and 10 days of treatment. The wound healing effects were the greatest in the -derived PDRN injection and -derived PDRN injection groups, which showed similar scores, followed by the -derived cream and normal saline soaked dressing groups. The injection of PDRN extracted from was found to be as effective at healing full-thickness skin defects as the -derived PDRN injection, which is currently used in the clinic. Moreover, the -derived PDRN injection was also found to reduce the time required for wound healing.